IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CONTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.408
NA - Nord America 7.781
AS - Asia 7.302
SA - Sud America 658
AF - Africa 159
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.329
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.547
CN - Cina 2.315
GB - Regno Unito 2.290
SG - Singapore 2.155
IT - Italia 1.991
DE - Germania 1.033
RU - Federazione Russa 809
SE - Svezia 582
HK - Hong Kong 580
BD - Bangladesh 441
IN - India 434
BR - Brasile 429
FR - Francia 390
VN - Vietnam 385
NL - Olanda 270
TR - Turchia 249
KR - Corea 216
IE - Irlanda 211
UA - Ucraina 187
FI - Finlandia 182
JP - Giappone 148
CA - Canada 137
ID - Indonesia 100
ES - Italia 94
EU - Europa 93
CO - Colombia 74
DK - Danimarca 67
AR - Argentina 57
PL - Polonia 52
PH - Filippine 47
CH - Svizzera 46
MX - Messico 44
CI - Costa d'Avorio 43
BE - Belgio 42
GR - Grecia 33
PK - Pakistan 33
IQ - Iraq 29
AT - Austria 27
TW - Taiwan 24
VE - Venezuela 23
ZA - Sudafrica 22
CL - Cile 21
PT - Portogallo 21
EC - Ecuador 19
MA - Marocco 17
RO - Romania 17
SA - Arabia Saudita 17
TH - Thailandia 17
UZ - Uzbekistan 17
AU - Australia 15
PY - Paraguay 14
EG - Egitto 13
KE - Kenya 13
MY - Malesia 13
PE - Perù 11
CR - Costa Rica 10
CZ - Repubblica Ceca 10
IR - Iran 10
JO - Giordania 10
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
AZ - Azerbaigian 7
HN - Honduras 7
HU - Ungheria 7
KZ - Kazakistan 7
NO - Norvegia 7
NP - Nepal 7
SC - Seychelles 7
IL - Israele 6
JM - Giamaica 6
LT - Lituania 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
EE - Estonia 5
ET - Etiopia 5
NG - Nigeria 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
BO - Bolivia 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
AM - Armenia 3
BB - Barbados 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
AL - Albania 2
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BZ - Belize 2
GH - Ghana 2
KG - Kirghizistan 2
Totale 24.380
Salva come PNG Salva come JPEG
Città #
Southend 2.041
Singapore 1.246
Milan 833
Ashburn 736
Hong Kong 527
San Jose 463
Chandler 441
Beijing 430
Dallas 375
Seattle 371
Council Bluffs 315
Santa Clara 303
Princeton 293
Wilmington 293
Fairfield 283
Ann Arbor 241
Frankfurt am Main 212
Dublin 204
Los Angeles 174
Woodbridge 161
New York 154
Dearborn 152
Nanjing 150
Hanover 149
Houston 141
Mountain View 134
Bengaluru 132
Lauterbourg 129
Guangzhou 126
Boardman 123
Jacksonville 117
Redmond 114
Ho Chi Minh City 107
Hefei 106
Hanoi 101
Buffalo 95
Moscow 89
Cambridge 87
Shanghai 85
Munich 83
Tokyo 81
Des Moines 73
Phoenix 72
Redwood City 72
Jinan 69
Sakarya 69
Somerville 68
Helsinki 65
Toronto 63
Shenyang 62
Grafing 60
Cangzhou 57
Rome 55
Serra 55
Bogotá 53
Andover 51
Jakarta 50
Tianjin 46
The Dalles 44
Abidjan 43
Seoul 43
Changsha 37
São Paulo 36
Columbus 35
Hangzhou 35
Brussels 33
Athens 32
Berlin 31
Hamburg 31
Nanchang 31
Atlanta 30
Hebei 30
Bologna 29
Eitensheim 29
Mumbai 28
Murcia 28
Chicago 27
San Diego 27
Naples 26
Odernheim 26
Verona 26
Nuremberg 25
Wuhan 25
Istanbul 23
Warsaw 23
Zhengzhou 23
Fuzhou 22
London 22
Medford 22
Orem 22
Jiaxing 21
Madrid 21
Monza 21
Amsterdam 20
Genoa 19
Ningbo 19
Paris 19
Shenzhen 19
Bühl 18
Siracusa 18
Totale 14.576
Salva come PNG Salva come JPEG
Nome #
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 438
Covalent inhibitors of GAPDH : From unspecific warheads to selective compounds 399
Folates in Trypanosoma brucei: achievements and opportunities 346
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents 324
Marine microorganisms as source of stereoselective esterases and ketoreductases : kinetic resolution of a prostaglandin intermediate 315
Structural basis of subunit-selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits 310
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 302
An efficient continuous flow process for the synthesis of a non-conventional mixture of fructooligosaccharides 299
The Glial Glutamate Transporter 1 (GLT1) is Expressed by Pancreatic beta-Cells and Prevents Glutamate-Induced beta-Cell Death 297
Immobilized enzyme reactors based on nucleoside phosphorylases and 2′-deoxyribosyltransferase for the in-flow synthesis of pharmaceutically relevant nucleoside analogues 287
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 283
Synthesis and pharmacological characterization at glutamate receptors of erythro- and threo-tricholomic acid and homologues thereof 281
The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death 280
γ-Glutamyl-dipeptides : Easy tools to rapidly probe the stereoelectronic properties of the ionotropic glutamate receptor binding pocket 279
Enzymatic continuous-flow preparation of nature-inspired phenolic esters as antiradical and antimicrobial noagents 274
Chemoenzymatic synthesis in flow reactors: a rapid and convenient preparation of Captopril 269
Biotransformation with whole microbial systems in a continuous flow reactor : resolution of (RS)-flurbiprofen using Aspergillus oryzae by direct esterification with ethanol in organic solvent 266
Sweet-and-salty biocatalysis : fructooligosaccharides production using Cladosporium cladosporioides in seawater 259
Flow-based stereoselective reduction of ketones using an immobilized ketoreductase/glucose dehydrogenase mixed bed system 258
An enzymatic flow-based preparative route to vidarabine 257
3-Carboxy-pyrazolinalanine as a new scaffold for developing potent and selective NMDA receptor antagonists 256
Use of Immobilized Amine Transaminase from Vibrio fluvialis under Flow Conditions for the Synthesis of (S)-1-(5-Fluoropyrimidin-2-yl)-ethanamine 251
Synthesis and structure-activity relationships in a set of new antimuscarinic agents 249
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake 246
Molecular basis for covalent inhibition of glyceraldehyde-3-phosphate dehydrogenase by a 2-phenoxy-1,4-naphthoquinone small molecule 244
Covalent Inhibitors of Plasmodium falciparum Glyceraldehyde 3-Phosphate Dehydrogenase with Antimalarial Activity in Vitro 242
Synthesis and pharmacological evaluation of novel conformationally constrained homologues of glutamic acid 239
Two examples of high-efficient and green biotransformations 237
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents 236
Innovative enzymatic (R,S)-flurbiprofen resolution in continuous flow reactor with lyophilized cells of Aspergillus oryzae 236
Synthesis of unusual isoxazoline containing β and γ-dipeptides as potential glutamate receptor ligands 236
Bicyclic γ-amino acids as inhibitors of γ-aminobutyrate aminotransferase 231
The chemoenzymatic continuous-flow synthesis of captopril 231
Synthesis of enantiomerically pure HIP-A and HIP-B and investigation of their activity as inhibitors of excitatory amino acid transporters 229
A regioselective route to 5-substituted pyrazole- and pyrazoline-3-phosphonic acids and esters 227
CTP synthetase inhibitors as new potential agents for the treatment of African Trypanosomiasis : synthesis and in vitro/in vivo evaluation of trypanocidal activity of 3-Br-Acivicin 227
Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity 227
Efficient synthesis of novel glutamate homologues and investigation of their affinity and selectivity profile at ionotropic glutamate receptors 227
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives 226
Synthesis, Binding Affinity at Glutamic Acid Receptors, Neuroprotective Effects, and Molecular Modeling Investigation of Novel Dihydroisoxazole Amino Acids 225
The impact of Chirality on Medicinal Chemistry 224
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds 223
Discovery and characterization of a new class of NAD+-independent SIRT1 activators 219
Design of Cyclopentaisoxazoline Amino Acids as Conformationally Constrained Agonists at Glutamate Receptors 214
Synthesis and Anticonvulsant Activity of Novel Bicyclic Acidic Amino Acids 213
Flow-based biocatalysis : application to peracetylated arabinofuranosyl-1,5-arabinofuranose synthesis 210
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antimicrobial and antiradical agents 209
Synthesis and biological evaluation of new amino acids structurally related to the antitumor agent acivicin 205
Synthesis and pharmacological characterization at glutamate receptors of the four enantiopure isomers of tricholomic acid 205
Regioselective Preparation of Functionalized Isoxazoline Derivatives, Key Intermediates in the Synthesis of Selective NMDA Receptor Antagonists 205
Synthesis of novel pyrrolo[3,4-d]pyrazole-dicarboxylic acids and evaluation of their interaction with glutamate receptors 204
Two-Step Flow Amidation of Natural Phenolic Acids as Antiradical and Antimicrobial Agents 203
Synthesis of L-tricholomic acid analogues and pharmacological characterization at ionotropic glutamate receptors 202
Synthesis and in vitro/in vivo Evaluation of the Antitrypanosomal Activity of 3-Bromoacivicin, a Potent CTP Synthetase Inhibitor 200
Discovery of covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase, a target for the treatment of malaria 199
Synthesis of Novel N1-Substituted Bicyclic Pyrazole Amino Acids and Evaluation of Their Interaction with Glutamate Receptors 190
A new chemoenzymatic approach to the synthesis of latanoprost and bimatoprost 190
(-)-HIP-A and (+)-HIP-B: investigation of the pharmacological profile and potential therapeutic applications 189
Design, synthesis and biological characterization of PfGAPDH inhibitors 186
Design and synthesis of novel isoxazole-based HDAC inhibitors 185
A new chemoenzymatic approach to the synthesis of Latanoprost and Bimatoprost 184
Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for Brain 183
An efficient method for the lipase-catalysed resolution and in-line purification of racemic flurbiprofen in a continuous-flow reactor 182
Synthesis and Biological Evaluation of CTP Synthetase Inhibitors as Potential Agents for the Treatment of African Trypanosomiasis 182
Enzymatic synthesis of ω-carboxy-β-hydroxy-(L)-α-amino acids 180
Synthesis of novel enantiopure 2-isoxazoline and 2-pyrazoline amino acids and their activity at glutamic acid receptors and transporters 179
Synthesis of new Delta(2)-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists 178
Design of Novel Conformationally Restricted Analogues of Glutamic Acid 177
One-pot chemoenzymatic synthesis of aldoximes from primary alcohols in water 176
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 175
Inhibition of Rhodesain as a Novel Therapeutic Modality for Human African Trypanosomiasis 175
Synthesis and pharmacological characterization of new analogs of broxaterol 174
UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 174
Design of a fully automated system for the synthesis of pharmaceutically relevant building blocks exploiting immobilized Rhodotorula rubra and new solvent systems 174
Synthesis of Conformationally Constrained Glutamic Acid Homologues and Investigation of Their Pharmacological Profiles 172
Continuous-flow stereoselective reduction of prochiral ketones in a whole cell bioreactor with natural deep eutectic solvents 172
Design, synthesis, and pharmacological characterization of novel, potent NMDA receptor antagonists 171
Synthesis and pharmacological characterization of the selective GluK1 radioligand (: S)-2-amino-3-(6-[3H]-2,4-dioxo-3,4-dihydrothieno[3,2- d] pyrimidin-1(2 H)-yl)propanoic acid ([3H]-NF608) 167
Synthesis and biological evaluation of papain-family cathepsinl-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents 166
A regioselective route to 5-substituted isoxazoline-3-phosphonates 164
Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis 163
Evading Pgp activity in drug-resistant cancer cells : a structural and functional study of antitubulin furan metotica compounds 159
Pichia Glucozyma: a powerful biocatalyst for enantioselective reduction of ketones 159
Inspired by Nature : The 3-Halo-4,5-dihydroisoxazole Moiety as a Novel Molecular Warhead for the Design of Covalent Inhibitors 159
Continuous biocatalysed redox reactions for the ecofriendly and improved synthesis of pharmaceutically relevant compounds 157
Stereoselective synthesis of 4-amino-3-hydroxy-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-4-carboxylic acid, a conformationally constrained analogue of aspartic acid 154
An improved synthesis of enantiomerically pure CIP-AS, a potent and selective AMPA-kainate receptor agonist 153
Dissociation of [3H]L-Glutamate Uptake from L-Glutamate-Induced [3H]D-Aspartate release by 3-Hydroxy-4,5,6,6atetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic Acid and 3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic Acid, Two Conf 152
Chemoenzymatic synthesis of the enantiomers of desoxymuscarine 151
Synthesis and Pharmacological Evaluation of (42) Nicotinic Ligands with a 3-Fluoropyrrolidine Nucleus 149
Synthesis of 3-hydroxy- and 3-carboxy-Delta(2)-isoxazoline amino acids and evaluation of their interaction with GABA receptors and transporters 148
Synthesis of new β- and γ-benzyloxy-S-glutamic acid derivatives and evaluation of their activity as inhibitors of excitatory amino acid transporters 148
Synthesis of TBOA homologues and evaluation of their activity as Glutamate transporter inhibitors 147
Use of a O-benzyl-(S)-serine containing eluent for the efficient ligand-exchange chromatography-based enantioseparation of constrained glutamate receptor ligands 147
Enantiomeric forms of (±)-HIP-A and (±)-HIP-B : synthesis and evalutation of their activity at the excitatory amino acids 146
Synthesis of (3-hydroxy-pyrazolin-5-yl)glycine based ligands interacting with ionotropic glutamate receptors 145
Synthesis of new isoxazoline-based acidic amino acids and investigation of their affinity and selectivity profile at ionotropic glutamate receptors 144
Synthesis and biological evaluation of new ligands designed to selectively interact with kainate receptors 144
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 144
Synthesis and binding affinity of new muscarinic ligands structurally related to oxotremorine 143
Totale 21.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 0 116
2021/20221.918 156 60 77 76 129 307 196 142 144 207 144 280
2022/20231.929 250 148 161 185 235 344 52 137 205 38 130 44
2023/20241.382 63 113 77 95 270 66 81 111 46 91 172 197
2024/20253.745 176 340 116 364 346 131 84 454 190 363 292 889
2025/20267.484 652 504 856 644 723 472 673 458 781 595 935 191
Totale 25.718